MedPath

A randomized controlled study of photodynamic therapy combined with Xuefu Zhuyu capsule in the treatment of oral leukoplakia with Qi stagnation and blood stasis

Phase 1
Recruiting
Conditions
Oral leukoplakia
Registration Number
ITMCTR2100004429
Lead Sponsor
The Ninth People's Hospital Affiliated to Medical College of Shanghai Jiaotong University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Subjects aged 18-70 years.
2. Subjects of any gender.
3. Patients with oral leukoplakia diagnosed clinically and pathologically, and with epithelial dysplasia (leukoplakia stage III or above), TCM syndrome differentiation is consistent with qi stagnation and blood stasis syndrome.
4. Subjects without radiotherapy or chemotherapy.
5. Subjects whose general condition can tolerate the treatment plan.
6. The patients who read the informed consent form voluntarily participated in the project.

Exclusion Criteria

1. Pregnant or lactating women.
2. Patients with other oral mucosal diseases, tumors and psychosis.
3. Patients with poor general condition and intolerable treatment: the general condition was judged by the first routine examination, such as three routine examinations and blood biochemical examination, with HB < 60g / L and WBC < 3.0 x 10^9 /L, PLT < 80 x 10^9 / L and serum creatinine > 133 umol / L, it was considered that the general condition was poor and the treatment could not be carried out smoothly.
4. Subjects allergic to photosensitizer and Xuefu Zhuyu Capsule.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TCM clinical syndrome scores;Recurrence of parts;TTR;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath